Evidence map›Paper›PMID 25937814›Full record

ArticleCurrent genomics2015

DNA secondary structure at chromosomal fragile sites in human disease.

Ryan G Thys, Christine E Lehman, Levi C T Pierce, Yuh-Hwa Wang

Open access · bronzeAbstract read
In one paragraph

Article in Current genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. The remodeling of Z-DNA in the mammalian germ line.Biochemical Society transactions · 2022
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ryan G ThysDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, USA.
Christine E LehmanDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, USA.
Levi C T PierceHuman Longevity, Inc., San Diego, California 92121, USA.
Yuh-Hwa WangDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.
Wake Forest University · USHuman Longevity (United States) · USUniversity of Virginia · US

Funding

Genome-wide DNA Secondary Structure Analysis to Investigate DNA FragilityR01GM101192 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WANG, YUH-HWA · 2013 to 2024
$2.8M
The Role of Fragile Sites in RET/PTC RearrangementR01CA113863 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WANG, YUH-HWA · 2006 to 2018
$2.5M
NCI NIH HHS R01 CA113863NIGMS NIH HHS R01 GM101192
6 · The paper itself

Abstract

DNA has the ability to form a variety of secondary structures that can interfere with normal cellular processes, and many of these structures have been associated with neurological diseases and cancer. Secondary structure-forming sequences are often found at chromosomal fragile sites, which are hotspots for sister chromatid exchange, chromosomal translocations, and deletions. Structures formed at fragile sites can lead to instability by disrupting normal cellular processes such as DNA replication and transcription. The instability caused by disruption of replication and transcription can lead to DNA breakage, resulting in gene rearrangements and deletions that cause disease. In this review, we discuss the role of DNA secondary structure at fragile sites in human disease.

Indexed as

CancerDNA fragilityDNA secondary structureFragile siteGenome instabilityNeurological disease.

Identifiers

PMID25937814
PMCPMC4412965
OpenAlexW2329393777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.